Today, Peter Menziuso and Carol Lakkis, BScOptom, PhD, represented Johnson & Johnson Vision alongside fellow eye health advocates in Washington, D.C., to underscore the company's commitment to eye health and patient safety during the Federal Trade Commission's (FTC) public workshop.
The workshop was held as part of the FTC's scheduled, 10-year review of the Contact Lens Rule and served as an opportunity for key stakeholders to share their feedback on how proposed changes may impact the patient-doctor relationship and consumers' access to innovative contact lenses—both now and in the future.
During the workshop, Mr. Menziuso, President, North America and Dr. Lakkis, Clinical Research Fellow, both of Johnson & Johnson Vision Care, underscored the benefits of a robust contact lens marketplace for consumers that promotes a positive patient experience while minimizing health-related risks.
"Three things are critical to ensuring a healthy eye health community – both now and in the future," Mr. Menziuso said. "First, is continuing to promote the importance of the doctor-patient relationship and regular, comprehensive eye exams. Next, is making sure patients receive the exact contact lenses as prescribed, regardless of where they choose to purchase. And lastly, we believe that contact lens wearers deserve care consistent with the high standard of care they receive in their eye doctor's office, regardless of where or how they receive it."
As the global market leader in contact lenses, Johnson & Johnson Vision is dedicated to advocating on behalf of initiatives that place the eye health and safety of the people who rely on our products first, at every step—passionately pursuing new technologies that meet high quality standards and improving and restoring sight for patients worldwide.
Mr. Menziuso and Dr. Lakkis represent Johnson & Johnson Vision through its operating company, Johnson & Johnson Vision Care, Inc.
To learn more about our commitment to eye health and vision safety, please visit https://jnjvisioncareinfo.com/.